Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Norbert Perrimon, Ph.D.


This page shows the publications co-authored by Norbert Perrimon and Justin Bosch.
Connection Strength

  1. Precise genome engineering in Drosophila using prime editing. Proc Natl Acad Sci U S A. 2021 01 05; 118(1).
    View in: PubMed
    Score: 0.938
  2. Proximity-dependent labeling methods for proteomic profiling in living cells: An update. Wiley Interdiscip Rev Dev Biol. 2021 01; 10(1):e392.
    View in: PubMed
    Score: 0.918
  3. Gene Knock-Ins in Drosophila Using Homology-Independent Insertion of Universal Donor Plasmids. Genetics. 2020 01; 214(1):75-89.
    View in: PubMed
    Score: 0.865
  4. Proteomics of protein trafficking by in vivo tissue-specific labeling. Nat Commun. 2021 04 22; 12(1):2382.
    View in: PubMed
    Score: 0.239
  5. Use of the CRISPR-Cas9 System in Drosophila Cultured Cells to Introduce Fluorescent Tags into Endogenous Genes. Curr Protoc Mol Biol. 2020 03; 130(1):e112.
    View in: PubMed
    Score: 0.221
  6. An in vivo RNAi screen uncovers the role of AdoR signaling and adenosine deaminase in controlling intestinal stem cell activity. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):464-471.
    View in: PubMed
    Score: 0.218
  7. Author Correction: Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2020 Jan; 38(1):108.
    View in: PubMed
    Score: 0.055
  8. Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2018 10; 36(9):880-887.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.